Tradename | Company | Number | Date | Products |
---|---|---|---|---|
OMNISCAN | GE Healthcare | N-020123 RX | 1993-01-08 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
omniscan | New Drug Application | 2025-03-11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 1 | — | 1 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | 1 | — | 1 |
Renal insufficiency | D051437 | — | N19 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Arterial occlusive diseases | D001157 | EFO_0009085 | — | — | — | 1 | — | — | 1 |
Renal artery obstruction | D012078 | EFO_1001150 | N28.0 | — | — | 1 | — | — | 1 |
Drug common name | Gadodiamide |
INN | gadodiamide |
Description | Gadodiamide, sold under the brand name Omniscan, is a gadolinium-based MRI contrast agent (GBCA), used in magnetic resonance imaging (MRI) procedures to assist in the visualization of blood vessels.
|
Classification | Small molecule |
Drug class | gadolinium derivatives (principally for diagnostic use) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 122795-43-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1200346 |
ChEBI ID | 37333 |
PubChem CID | 60754 |
DrugBank | DB00225 |
UNII ID | 84F6U3J2R6 (ChemIDplus, GSRS) |